AstroNova (ALOT) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Dec, 2025Executive summary
Q3 FY26 revenue was $39.2M, up 8.5% sequentially but down 3.1% year-over-year, with net income of $0.4M ($0.05 per share); both Product ID and Aerospace segments contributed to sequential growth, though Aerospace declined year-over-year.
Gross margin improved to 36.2% in Q3 (up 230 bps year-over-year), driven by favorable product mix and cost reductions; adjusted EBITDA margin reached 10.7%.
Strong cash generation in Q3, with $3.4M in operating cash flow and $13.5M in liquidity; debt reduced by $3.2M in the quarter and $6.4M year-to-date.
Restructuring actions included a 10% workforce reduction and MTEX portfolio realignment, expected to yield $3M in annualized savings; $0.3M goodwill impairment and $1.3M restructuring charges recognized.
Refinanced credit facility, extending maturity to 2028, consolidating foreign debt, and lowering principal payments.
Financial highlights
Q3 FY26 revenue: $39.2M (down 3.1% YoY, up 8.5% sequentially); gross profit: $14.2M (up 3.5% YoY); gross margin: 36.2%.
Net income: $0.4M ($0.05/share); adjusted EBITDA: $4.2M (10.7% margin); operating income: $1.3M (3.3% margin).
Cash from operations: $3.4M for Q3, $8.1M year-to-date; total liquidity at quarter end: $13.5M.
Net debt leverage ratio at 3.38, below the 4.75 covenant; fixed charge coverage ratio at 1.27, above the 1.05 requirement.
Capital expenditures were $86,000 for the quarter and $0.2M year-to-date.
Outlook and guidance
FY26 revenue guidance reiterated at $149M–$154M, with Q4 revenue expected at $36M–$41M.
Adjusted EBITDA margin for FY26 expected in the 7.5%–8.5% range.
Anticipates margin tailwind in FY27 from expiration of a major royalty agreement in Aerospace.
Restructuring expected to complete by end of FY26, with $3M in annualized savings.
Management anticipates improved Product ID performance as MTEX integration progresses.
Latest events from AstroNova
- Recurring revenue, acquisitions, and innovation drive growth and margin expansion.ALOT
Sidoti Micro-Cap Virtual Conference2 Feb 2026 - Q1 revenue down 7%, net income up, and MTEX NS acquisition boosts future growth.ALOT
Q1 20251 Feb 2026 - Q2 revenue up 14.1% with margin gains; MTEX integration impacts near-term profitability.ALOT
Q2 202520 Jan 2026 - Accelerating growth through innovation, acquisitions, and operational excellence.ALOT
2024 Southwest IDEAS Conference13 Jan 2026 - Revenue up 7.7% but net income and margins fell sharply amid MTEX integration challenges.ALOT
Q3 202511 Jan 2026 - Board recommends its director slate, annual say-on-pay, and auditor ratification amid proxy contest.ALOT
Proxy Filing1 Dec 2025 - Board recommends its nominees and strategic direction amid proxy contest and operational changes.ALOT
Proxy Filing1 Dec 2025 - Six director nominees proposed, board rejects dissident slate to protect strategic direction.ALOT
Proxy Filing1 Dec 2025 - Annual meeting features director elections, executive pay votes, and auditor ratification.ALOT
Proxy Filing1 Dec 2025